Skip to search formSkip to main contentSkip to account menu

eldecalcitol

Known as: (5z,7e)-2Beta-(3-Hydroxypropoxy)-9,10-Secocholesta-5,7,10(19)-Triene-1Alpha,3Beta,25-Triol, 1?,25-dihydroxy-2?-(3-hydroxypropoxy)cholecalciferol 
National Institutes of Health

Related topics

Related topics

3 relations

Narrower (1)

20-epi-eldecalcitol

Broader (1)

Vitamin D
analogs & derivatives

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2019
2019
Eldecalcitol, an active vitamin D analog, effectively prevents cyclophosphamide-induced osteoporosis in rats
Cyclophosphamide (CTX) as an alkylating agent is used for treating a range of tumor types and allergic diseases. However, high… 
2018
2018
Metabolism of 2α-[2-(tetrazol-2-yl)ethyl]-1α,25-dihydroxyvitamin D3 by CYP24A1 and biological activity of its 24R-hydroxylated metabolite
2017
2017
Further significant effects of eldecalcitol on bone resorption markers and bone mineral density in postmenopausal osteoporosis patients having undergone long-term bisphosphonate treatment
We investigated whether eldecalcitol has further significant effects on bone metabolic markers and bone mineral density (BMD) in… 
2016
2016
Eldecalcitol prevents endothelial dysfunction in postmenopausal osteoporosis model rats.
Postmenopausal women have high incidence of cardiovascular events as estrogen deficiency can cause endothelial dysfunction… 
2012
2012
Osteoporosis Treatment by a New Active Vitamin D3 Compound, Eldecalcitol, in Japan
Although vitamin D is used mainly as a nutritional supplement in osteoporosis treatment, its active form, 1,25-dihydroxyvitamin D… 
2012
2012
Eldecalcitol normalizes bone turnover markers regardless of their pre-treatment levels
Abstract Background: Three-year treatment with eldecalcitol has been shown to improve lumbar and total hip bone mineral density… 
2012
2012
Process development for the practical production of eldecalcitol by linear, convergent and biomimetic syntheses.
Eldecalcitol [1α,25-dihydroxy-2β-(3-hydroxypropoxy)vitamin D(3)], an analog of calcitriol (1α,25-dihydroxyvitamin D(3… 
2012
2012
Spotlight on Eldecalcitol in Osteoporosis
Eldecalcitol (1α,25[OH]2-2β-(3-hydroxypropyloxy)vitamin D3; ED-71; Edirol®) is an orally administered analogue of active vitamin… 
Review
2011
Review
2011
Overview of the clinical pharmacokinetics of eldecalcitol, a new active vitamin D3 derivative
Eldecalcitol, which was developed by Chugai Pharmaceutical Co., Ltd. as a treatmentwith the potential of becoming the drug of… 
Review
2009
Review
2009
D-hormone derivatives for the treatment of osteoporosis: from alfacalcidol to eldecalcitol.
Many readers may have only a vague idea about vitamin D. This is made complicated, in part, because it is also expressed with… 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)